NRBP1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.820600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.887020E-01
Normal-vs-Stage2
5.317800E-01
Normal-vs-Stage3
5.142600E-01
Normal-vs-Stage4
7.939200E-01
Stage1-vs-Stage2
2.136200E-01
Stage1-vs-Stage3
6.822000E-01
Stage1-vs-Stage4
6.620100E-02
Stage2-vs-Stage3
6.399400E-01
Stage2-vs-Stage4
3.051200E-01
Stage3-vs-Stage4
3.166600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.699600E-01
Normal-vs-AfricanAmerican
6.380800E-01
Normal-vs-Asian
5.822400E-01
Caucasian-vs-AfricanAmerican
6.081600E-01
Caucasian-vs-Asian
8.077400E-01
AfricanAmerican-vs-Asian
7.489600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.526400E-01
Normal-vs-Female
5.263600E-01
Male-vs-Female
4.531400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.324000E-01
Normal-vs-Age(41-60Yrs)
8.644800E-01
Normal-vs-Age(61-80Yrs)
3.578600E-01
Normal-vs-Age(81-100Yrs)
3.040000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.577030E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.708000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.587800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.018400E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.512400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.933800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.915350E-01
Normal-vs-Daily Drinker
5.754200E-01
Normal-vs-Weekly Drinker
9.010600E-01
Normal-vs-Occasional Drinker
3.838600E-01
Normal-vs-Social Drinker
7.048800E-01
Non Drinker-vs-Daily Drinker
2.561400E-01
Non Drinker-vs-Weekly Drinker
5.728500E-02
Non Drinker-vs-Occasional Drinker
2.474400E-01
Non Drinker-vs-Social Drinker
4.999600E-02
Daily Drinker-vs-Weekly Drinker
4.502600E-01
Daily Drinker-vs-Occasional Drinker
9.209400E-01
Daily Drinker-vs-Social Drinker
5.308000E-01
Weekly Drinker-vs-Occasional Drinker
3.361800E-01
Weekly Drinker-vs-Social Drinker
8.044200E-01
Occasional Drinker-vs-Social Drinker
3.551400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.742000E-01
Normal-vs-Grade 2
8.688600E-01
Normal-vs-Grade 3
8.243800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.815910E-03
Grade 1-vs-Grade 3
1.199150E-03
Grade 1-vs-Grade 4
9.742000E-01
Grade 2-vs-Grade 3
2.755200E-01
Grade 2-vs-Grade 4
8.688600E-01
Grade 3-vs-Grade 4
8.243800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.001600E-01
Normal-vs-NonDiabetic
4.449600E-01
Diabetic-vs-NonDiabetic
8.023200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.134800E-01
Normal-vs-NoPancreatitis
4.478800E-01
Pancreatitis-vs-NoPancreatitis
2.013200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.153800E-01
Normal-vs-N1
5.861000E-01
N0-vs-N1
2.613400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.417800E-01
Normal-vs-TP53-NonMutant
1.519960E-01
TP53-Mutant-vs-TP53-NonMutant
4.120400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
